These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 18343636)
1. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636 [TBL] [Abstract][Full Text] [Related]
2. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects. de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190 [TBL] [Abstract][Full Text] [Related]
3. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients. de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036 [TBL] [Abstract][Full Text] [Related]
4. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226 [TBL] [Abstract][Full Text] [Related]
5. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014 [TBL] [Abstract][Full Text] [Related]
6. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose. de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213 [TBL] [Abstract][Full Text] [Related]
7. Physical activity is associated with risk factors for chronic disease across adult women's life cycle. Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225 [TBL] [Abstract][Full Text] [Related]
8. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953 [TBL] [Abstract][Full Text] [Related]
9. Increase in visfatin after weight loss induced by gastroplastic surgery. Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602 [TBL] [Abstract][Full Text] [Related]
10. Re: Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Erdem G; Ercin CN; Dogru T; Tasci I; Sonmez A Nutrition; 2009 Feb; 25(2):240. PubMed ID: 18947975 [No Abstract] [Full Text] [Related]
11. Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women. Andreoli A; Lauro S; Di Daniele N; Sorge R; Celi M; Volpe SL Eur J Clin Nutr; 2008 Jul; 62(7):892-7. PubMed ID: 17522604 [TBL] [Abstract][Full Text] [Related]
12. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. Brinkworth GD; Noakes M; Buckley JD; Clifton PM Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: relationship with insulin resistance. De Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Castro MJ; Romero E Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1031-6. PubMed ID: 21375135 [TBL] [Abstract][Full Text] [Related]
14. Changes of ghrelin and leptin in response to hypocaloric diet in obese patients. de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O Nutrition; 2008 Feb; 24(2):162-6. PubMed ID: 18165128 [TBL] [Abstract][Full Text] [Related]
15. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Oki K; Yamane K; Kamei N; Nojima H; Kohno N Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078 [TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298 [TBL] [Abstract][Full Text] [Related]
17. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol. Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865 [TBL] [Abstract][Full Text] [Related]
18. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420 [TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers. Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361 [TBL] [Abstract][Full Text] [Related]
20. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Alghasham AA; Barakat YA Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]